有创冠状动脉功能检测的安全性、可行性与诊断率:荷兰注册研究
该研究基于荷兰有创冠状动脉血管运动功能检测注册(NL-CFT),纳入1207例有心绞痛但无阻塞性冠脉疾病的患者,在15家医院(2家三级、13家非三级)行冠状动脉功能检测。结果显示血管运动功能障碍患病率高达78%,主要并发症0.9%、次要并发症0.8%,无操作相关死亡、心梗或卒中,三级与非三级中心并发症无差异。
要点
- 有心绞痛且无阻塞性冠脉疾病者中血管运动功能障碍患病率高达78%。
- 冠状动脉功能检测主要并发症0.9%、次要并发症0.8%,无操作相关死亡、心梗或卒中。
- 三级与非三级中心并发症发生无差异,提示该检测可在非三级中心安全开展。
核心结论
- 冠状动脉功能检测在三级与非三级中心均可行且安全,诊断率很高。
研究设计与样本
- 质量改进研究,使用荷兰有创冠状动脉血管运动功能检测前瞻性观察注册(NL-CFT),共15家医院(2家三级、13家非三级)。
- 纳入2020年12月至2024年1月因临床指征转诊行冠状动脉功能检测的心绞痛且无阻塞性冠脉疾病患者,共1207例,其中女性978例(81%),平均(SD)年龄60(10)岁。
主要发现
- 冠状动脉血管运动功能障碍患病率为78%。
- 主要并发症11例(0.9%),次要并发症10例(0.8%);其中3例主要并发症及全部次要并发症明确与冠状动脉功能检测相关。
- 未观察到操作相关死亡、心肌梗死或卒中。
- 三级与非三级中心并发症发生无差异。
关键数值与推荐
- 完整冠状动脉功能检测包括乙酰胆碱痉挛激发试验和微循环功能评估。
临床怎么用
- 对心绞痛且无阻塞性冠脉疾病患者,可考虑行冠状动脉功能检测以明确血管运动功能障碍。
- 该检测在非三级中心亦可行且安全,可支持其临床推广。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Patients with angina and no obstructive coronary artery disease frequently have coronary vasomotor dysfunction as underlying pathophysiological mechanism, comprising epicardial spasm, microvascular spasm, and/or microcirculatory dysfunction. These endotypes can be diagnosed by invasive coronary function testing which has previously shown to be safe in tertiary and expert centers. OBJECTIVE: To determine the prevalence of vasomotor dysfunction in patients with angina and no obstructive coronary artery disease who were clinically referred for a coronary function test (CFT); and assess safety and feasibility of a CFT. DESIGN, SETTING, AND PARTICIPANTS: This quality improvement study was performed using the Netherlands Registry of Invasive Coronary Vasomotor Function Testing (NL-CFT), a prospective, observational registry, in 15 participating hospitals (2 tertiary and 13 nontertiary). Patients with angina and no obstructive coronary artery disease who were referred for a clinically indicated CFT between December 2020 and January 2024 were included. MAIN OUTCOMES AND MEASURES: A complete CFT consisted of acetylcholine spasm provocation testing and assessment of microcirculatory function. Prevalence of different endotypes based on test results and overall safety were assessed. RESULTS: Among a total of 1207 patients included, 978 (81%) were female; and the mean (SD) age was 60 (10) years. The prevalence of coronary vasomotor dysfunction was very high (78%). There were 11 (0.9%) major and 10 (0.8%) minor complications reported. Of them, 3 major and all minor were definitely related to the coronary function test. No procedural death, myocardial infarction, or stroke was observed. No differences were found in the occurrence of complications between tertiary and nontertiary centers. CONCLUSIONS AND RELEVANCE: This study found that a CFT was feasible and safe to perform in both tertiary and nontertiary centers with a high diagnostic yield.
引用
- Crooijmans C, Jansen TPJ, Meeder JG, et al. Safety, Feasibility, and Diagnostic Yield of Invasive Coronary Function Testing: Netherlands Registry of Invasive Coronary Vasomotor Function Testing. JAMA Cardiol. 2025. PMID: 39969865. doi:10.1001/jamacardio.2024.5670
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。